ANMAT Lifts Biotenk Ban: The Impact of Fontana’s Decree 676/2026 Under Milei’s Government

Preston Policy & Gazette Monitor

Introduction to the ANMAT Decision The National Administration of Drugs, Foods and Medical Technology (ANMAT) plays a crucial role in the regulation and oversight of health products in Argentina. Established in 1992, ANMAT is responsible for the protection of public health through the regulation of pharmaceuticals, medical devices, and food products. This government agency ensures … Read more

ANMAT Revokes Marketing Authorizations for Inmunolab S.A.: Analyzing the Implications

Preston Policy & Gazette Monitor

Overview of ANMAT Disposition 338/2026 On February 6, 2026, the National Administration of Drugs, Food and Medical Technology (ANMAT) issued Disposition 338/2026, a critical regulatory decision that has significant implications for public health and safety in Argentina. This ruling specifically revokes the marketing authorizations for the products of Inmunolab S.A., a manufacturer operating within pharmaceutical … Read more